International Business Leader - Coagulation, Hematology and Urinalysis

Bei Roche kannst du ganz du selbst sein und wirst für deine einzigartigen Qualitäten geschätzt. Unsere Kultur fördert persönlichen Ausdruck, offenen Dialog und echte Verbindungen. Hier wirst du für das, was du bist, wertgeschätzt, akzeptiert und respektiert. Dies schafft ein Umfeld, in dem du sowohl persönlich als auch beruflich wachsen kannst. Gemeinsam wollen wir Krankheiten vorbeugen, stoppen und heilen und sicherstellen, dass jeder Zugang zur Gesundheitsversorgung hat - heute und in Zukunft.

Werde Teil von Roche, wo jede Stimme zählt.

A healthier future. It's what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love. That's what makes us Roche.

At Roche Diagnostics, we are driven by our vision: innovating diagnostics, shaping healthcare, and changing lives. We are excited to see this vision come to life.

Roche Diagnostic Solutions is responsible for delivering on our Diagnostics Strategy. Within this, the Core Lab business area plays a key role: we strive to expand global access to innovative diagnostics and empower our customers to improve patient outcomes across the healthcare continuum.

By increasing access and setting new standards in core laboratory diagnostics, we provide efficient, end-to-end testing systems and high medical-value solutions, leveraging the full strength of our One Roche approach.

The International Business Leader (IBL) – Coagulation, Hematology & Urinalysis (CHU) is responsible for driving the global strategic vision, commercial success, and market development for the CHU product portfolio within Core Lab, Roche Diagnostics Solutions (RDS). In addition, the IBL would support strategy development and implementation of Core Lab 3rd Party eco‑system activities. This role leads the International Business Team (IBT), identifying international market opportunities, filling portfolio gaps, and aligning commercial strategy with global regions and affiliates.

Key Accountabilities

The key accountabilities for this position include, but are not limited to:

• Strategic Vision & LCT Leadership:
  Creates and executes the long‑term strategic commercial vision for the Coagulation, Hematology & Urinalysis Life Cycle Team (LCT) and 3rd party Eco‑system. Accountable for the overall commercial success and systematic lifecycle development of the portfolio.

• Global Marketing & Launch Planning:
  Develops, refines, and implements the Global Marketing Plan and strategic launch roadmaps across assigned product lines (e.g., Coagulation, Urinalysis, Hematology instruments and assays).

• IBT & Functional Team Leadership:
  Heads the International Business Team (IBT). Leads, coaches, and empowers International Product Managers (IPMs) and cross‑functional team members while cultivating a high‑performing, inclusive culture.

• Budget & Commercial Operations:
  Manages the rolling global LCT marketing budget, optimizing allocations and making recommendations in response to market dynamics, IP/risk assessments, and affiliate needs.

• Cross‑Functional & Ecosystem Alignment:
  Serves as the key commercial interface across multiple system lifecycle teams (e.g., cobas ULTRA ecosystem), R&D, Medical Affairs, Regulatory, Operations/Supply Chain, IP/Law, and Global Marketing (M&CI), and 3rd Party partners. Proxy for the Life Cycle Leader (LCL) on select strategic topics.

• Market Execution &
  
  Risk Management:
  
  Identifies growth opportunities and mitigates commercial/market risks. Directs execution for key commercial activities including global congress presence (e.g., EML), product positioning, messaging, pricing strategies, and affiliate…